^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

ALK wild-type

i
Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
Entrez ID:
over1year
Clinical
|
EGFR (Epidermal growth factor receptor) • PD-L1 (Programmed death ligand 1) • PD-1 (Programmed cell death 1) • TIGIT (T Cell Immunoreceptor With Ig And ITIM Domains 2)
|
EGFR wild-type • ALK wild-type
|
Yutuo (zimberelimab) • domvanalimab (AB154) • etrumadenant (AB928)
over1year
Clinical
|
EGFR (Epidermal growth factor receptor)
|
EGFR wild-type • ALK wild-type
|
Imfinzi (durvalumab) • Imjudo (tremelimumab)
over1year
Clinical
|
EGFR (Epidermal growth factor receptor) • PD-L1 (Programmed death ligand 1) • ALK (Anaplastic lymphoma kinase)
|
PD-L1 expression • ALK positive • EGFR wild-type • ALK wild-type • EGFR positive